Press Release: Nanalysis Announces Management Changes

Dow Jones
10/05

CALGARY, AB, Oct. 5, 2026 /CNW/ -- Nanalysis Scientific Corp. (the "Company" or "Nanalysis") (TSXV: NSCI, FRA: 1N1) is pleased to announce the appointment of Philip Birkby as Interim Chief Financial Officer of the Company, effective October 5, 2026.

Philip Birkby, CPA, CA, is a senior finance leader with more than 25 years of experience in publicly traded and private organizations, primarily in the energy and financial services sectors. His experience spans financial reporting, corporate finance, capital allocation, treasury, risk management and corporate governance, and includes working closely with executive leadership teams and Boards on capital structure, liquidity, financing and enterprise risk. Mr. Birkby is a member of the Chartered Professional Accountants of Alberta and holds a Bachelor of Commerce degree.

Mr. Birkby succeeds Heather Kury whose tenure as Chief Financial Officer has concluded. The Board and the entire Nanalysis team would like to thank Ms. Kury for her service and contributions to the Company and wishes her the very best in her future endeavors.

About Nanalysis Scientific Corp. (TSXV: NSCI, FRA: 1N1)

Nanalysis Scientific Corp. develops and manufactures benchtop Nuclear Magnetic Resonance $(NMR)$ spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company also operates a growing services division that maintains both its own products and third-party imaging equipment, anchored by long-term contract to maintain security scanners at more than 85 Canadian airports.

Notice regarding Forward Looking Information and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. In particular, this news release contains forward-looking information in relation to:: the resignation of the Chief Financial Officer and the appointment of an interim Chief Financial Officer. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-management-changes-302897983.html

SOURCE Nanalysis Scientific Corp.

/CONTACT:

Copyright CNW Group 2026 
 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10